肝硬化背景下CT、MRI检查对肝癌的诊断价值.docVIP

精品论文 参考文献 肝硬化背景下CT、MRI检查对肝癌的诊断价值 胡碧华 梁洪 　　（四川省安岳县人民医院CT室 四川安岳 642350） 　　【摘要】 目的：探讨CT、MRI检查在肝硬化背景下对肝癌的诊断价值。方法：158例肝硬化患者分别于2周内行肝脏CT及MRI扫描，将扫描结果与最终诊断结果进行对比分析，探讨两种方法对肝硬化背景下肝癌的诊断价值。结果：本组158例患者中，最终诊断为肝癌129例，良性29例。其中CT诊断敏感度为72.9%（94/129），特异度为41.4%（12/29）；MRI诊断敏感度为86.0%（111/129），特异度为79.3%（23/29），MRI对肝硬化背景下肝癌诊断的敏感度及特异度均显著高于CT（P＜0.01）。结论：MRI对于肝硬化背景下肝癌诊断价值优于CT，但在实际临床工作中仍应结合多种影像学表现及临床表现、实验室检查结果等多方面资料综合分析，以提高肝硬化背景下肝癌的诊断准确性。 　　【关键词】 肝??化；CT；MRI；肝癌 　　【中图分类号】R445 【文献标识码】A 【文章编号】1007-8231（2016）10-0067-02 　　The Diagnostic Value of CT and MRI in Hepatocellular Carcinoma in Patients with Hepatic Cirrhosis Hu Bihua,Liang Hong. 　　Department of CT,Peoplersquo;s hospital of Anye county in Sichuan province Sichuan Anyue 642350,China 　　【Abstract】Objective To contrast the diagnostic value of CT and MRI in hepatocellular carcinoma in patients with hepatic cirrhosis. Methods 158 patients with hepatic cirrhosis were detected with CT and MRI within 2 weeks, and the results were compared with the final diagnosis, and the diagnostic value was analyzed. Results There were 129 patients were diagnosed with liver cancer, and 29 patients with benign lesions. And the sensitivity of CT in hepatocellular diagnosing was 72.9%(94/129), and the specificity was 41.4%(12/29); the sensitivity of MRI was 86.0%(111/129), specificity was 79.3%(23/29). The sensitivity and specificity of MRI were significantly higher than CT(P＜0.01). Conclusion The diagnostic value of MRI is better than CT in hepatocellular carcinoma in patients with hepatic cirrhosis, but we should combine a variety of imaging results and clinical manifestations, laboratory test results, and make a comprehensive analysis of data in order to improve the diagnostic accuracy of hepatocellular carcinoma in patients with hepatic cirrhosis. 　　【Key words】Hepatic Cirrhosis; CT; MRI; Hepatocellular 　　乙型肝炎在我国发病率较高，而在乙型肝炎基础上发生的原发性肝癌发病率也同样较高，原发性肝癌可发生于肝硬化之前，也可发生在肝硬化之后[1]。近年来随着外科手术、介入、射频消融等多方面治疗技术的不断发展，肝癌患者5年生存率得到了很大提高